Activist investor Elliott Investment Management has taken a large stake in Align Technology (ALGN), positioning itself to push for strategic changes to boost shareholder value. The move comes as Align struggles with weakened demand post-pandemic, though Q4 2025 showed record Invisalign volumes. Barclays upgraded the stock to Overweight with a $200 price target, citing recovery potential as geopolitical concerns stabilize and the stock trades below historical valuation multiples.

The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.

The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.

Align Technology reported record Invisalign case submissions in Q4 with 87.7 thousand doctors submitting cases. Revenue beat expectations at $1.048 billion (+5.3% YoY) and adjusted EPS of $3.29 surpassed consensus of $2.97. The company projects 3-4% revenue growth for fiscal 2026 with improving margins, sending shares up 10.43% in premarket trading.

The article highlights three under-the-radar tech stocks with potential upside: Align Technology, Marvell Technology, and EPAM Systems. These companies offer unique opportunities beyond the Magnificent Seven tech stocks, with strong fundamentals and growth potential in their respective niches.

Align Technology reported Q3 earnings beating analyst expectations, with sales growing less than 2% year-over-year. Despite a stock price increase, the company's earnings and free cash flow are declining, suggesting potential challenges.

Law firm investigating potential securities law violations by Align Technology after significant stock price drop following missed financial expectations in Q2 2025.

Pomerantz Law Firm is investigating potential securities fraud at Align Technology after the company missed revenue estimates, lowered guidance, and experienced a significant stock price drop of 36.63%.

Pomerantz Law Firm is investigating potential securities fraud at Align Technology after the company missed revenue estimates and lowered financial guidance, causing a significant stock price drop.

Law firm investigating potential securities law violations by Align Technology after significant stock price drop following missed financial expectations in Q2 2025.

Pomerantz Law Firm is investigating potential securities fraud by Align Technology after the company missed revenue estimates and lowered financial guidance, causing its stock price to drop 36.63%.

Light Lane Dental Practice in Coventry is offering free Invisalign consultations to help patients explore teeth straightening options without upfront costs, providing a discreet and flexible alternative to traditional metal braces.